During the past decade, HIV Institute / Davies Med Ctr conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "HIV Institute / Davies Med Ctr" are "HIV Infections" (4 trials) and "Leukoencephalopathy, Progressive Multifocal" (1 trials). Many other conditions were trialed in "HIV Institute / Davies Med Ctr" in a lesser frequency.

Most popular intervention types in "HIV Institute / Davies Med Ctr" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Indinavir sulfate" (2 trials), "Ritonavir" (2 trials), "Atazanavir" (1 trials), "Lamivudine" (1 trials) and "Nelfinavir mesylate" (1 trials). Other intervention names were less common.

The vast majority of trials in "HIV Institute / Davies Med Ctr" are 4 trials for "All" genders.

Currently, there are NaN active trials in "HIV Institute / Davies Med Ctr". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in HIV Institute / Davies Med Ctr, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in HIV Institute / Davies Med Ctr, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".